150 related articles for article (PubMed ID: 21459420)
1. Incidence, predictors and associated outcomes of renal cell carcinoma in long-term dialysis patients.
Hurst FP; Jindal RM; Fletcher JJ; Dharnidharka V; Gorman G; Lechner B; Nee R; Agodoa LY; Abbott KC
Urology; 2011 Jun; 77(6):1271-6. PubMed ID: 21459420
[TBL] [Abstract][Full Text] [Related]
2. Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis.
Satoh S; Tsuchiya N; Habuchi T; Ishiyama T; Seimo K; Kato T
J Urol; 2005 Nov; 174(5):1749-53. PubMed ID: 16217276
[TBL] [Abstract][Full Text] [Related]
3. Incidence, predictors, costs, and outcome of renal cell carcinoma after kidney transplantation: USRDS experience.
Hurst FP; Jindal RM; Graham LJ; Falta EM; Elster EA; Stackhouse GB; Agodoa LY; Lentine KL; Salifu MO; Abbott KC
Transplantation; 2010 Oct; 90(8):898-904. PubMed ID: 21248500
[TBL] [Abstract][Full Text] [Related]
4. Renal cell carcinoma in dialysis patients: a single center experience.
Kojima Y; Takahara S; Miyake O; Nonomura N; Morimoto A; Mori H
Int J Urol; 2006 Aug; 13(8):1045-8. PubMed ID: 16903927
[TBL] [Abstract][Full Text] [Related]
5. Renal cell carcinoma co-existent with other renal disease: clinico-pathological features in pre-dialysis patients and those receiving dialysis or renal transplantation.
Peces R; Martínez-Ara J; Miguel JL; Arrieta J; Costero O; Górriz JL; Picazo ML; Fresno M
Nephrol Dial Transplant; 2004 Nov; 19(11):2789-96. PubMed ID: 15316098
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic microangiopathy in United States long-term dialysis patients.
Perkins RM; Reynolds JC; Ahuja TS; Reid T; Agodoa LY; Bohen EM; Yuan CM; Abbott KC
Nephrol Dial Transplant; 2006 Jan; 21(1):191-6. PubMed ID: 16204286
[TBL] [Abstract][Full Text] [Related]
7. [Renal lesions in tuberous sclerosis].
Schillinger F; Montagnac R
Nephrol Ther; 2006 Jan; 2 Suppl 2():S123-6. PubMed ID: 17373212
[TBL] [Abstract][Full Text] [Related]
8. Chronic renal failure and its treatment in tuberous sclerosis.
Schillinger F; Montagnac R
Nephrol Dial Transplant; 1996 Mar; 11(3):481-5. PubMed ID: 8671819
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients.
Trivedi H; Xiang Q; Klein JP
Nephrol Dial Transplant; 2009 Jan; 24(1):258-66. PubMed ID: 18682489
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma in native kidneys of patients with end stage renal disease.
Shingleton WB; Blalock J; Clark J; Bigler SA
J Miss State Med Assoc; 1998 Mar; 39(3):86-9. PubMed ID: 9538592
[TBL] [Abstract][Full Text] [Related]
11. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States.
Kitiyakara C; Eggers P; Kopp JB
Am J Kidney Dis; 2004 Nov; 44(5):815-25. PubMed ID: 15492947
[TBL] [Abstract][Full Text] [Related]
12. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.
Wolfe RA; Ashby VB; Milford EL; Ojo AO; Ettenger RE; Agodoa LY; Held PJ; Port FK
N Engl J Med; 1999 Dec; 341(23):1725-30. PubMed ID: 10580071
[TBL] [Abstract][Full Text] [Related]
13. Risk for renal cell carcinoma in chronic hepatitis C infection.
Gordon SC; Moonka D; Brown KA; Rogers C; Huang MA; Bhatt N; Lamerato L
Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):1066-73. PubMed ID: 20332260
[TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis.
Nouh MA; Kuroda N; Yamashita M; Hayashida Y; Yano T; Minakuchi J; Taniguchi S; Nomura I; Inui M; Sugimoto M; Kakehi Y
BJU Int; 2010 Mar; 105(5):620-7. PubMed ID: 19747356
[TBL] [Abstract][Full Text] [Related]
15. End-stage renal disease patients on renal replacement therapy in the intensive care unit: short- and long-term outcome.
Bell M; Granath F; Schön S; Löfberg E; ; Ekbom A; Martling CR
Crit Care Med; 2008 Oct; 36(10):2773-8. PubMed ID: 18766088
[TBL] [Abstract][Full Text] [Related]
16. Synchronous renal cell carcinoma and multiple myeloma: report of two cases and review of the literature.
Ozturk MA; Dane F; Kaygusuz I; Asmaz O; Uzay A; Bayik M; Turhal NS
J BUON; 2009; 14(3):511-4. PubMed ID: 19810147
[TBL] [Abstract][Full Text] [Related]
17. Duration of end-stage renal disease and kidney transplant outcome.
Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
[TBL] [Abstract][Full Text] [Related]
18. Better survival of renal cell carcinoma in patients with inflammatory bowel disease.
Derikx LA; Nissen LH; Drenth JP; van Herpen CM; Kievit W; Verhoeven RH; Mulders PF; Hulsbergen-van de Kaa CA; Boers-Sonderen MJ; van den Heuvel TR; Pierik M; Nagtegaal ID; Hoentjen F; ; ;
Oncotarget; 2015 Nov; 6(35):38336-47. PubMed ID: 26447542
[TBL] [Abstract][Full Text] [Related]
19. Arteriovenous fistula use and heart disease in long-term elderly hemodialysis patients: analysis of United States Renal Data System Dialysis Morbidity and Mortality Wave II.
Abbott KC; Trespalacios FC; Agodoa LY
J Nephrol; 2003; 16(6):822-30. PubMed ID: 14736009
[TBL] [Abstract][Full Text] [Related]
20. Renal cell carcinoma and end stage renal disease.
Farivar-Mohseni H; Perlmutter AE; Wilson S; Shingleton WB; Bigler SA; Fowler JE
J Urol; 2006 Jun; 175(6):2018-20; discussion 2021. PubMed ID: 16697788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
